Pacer Advisors, Inc. Xencor Inc Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 543 shares of XNCR stock, worth $11,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
543
Previous 1,064
48.97%
Holding current value
$11,658
Previous $23,000
56.52%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XNCR
# of Institutions
204Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$238 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$196 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$150 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$114 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$85.1 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.28B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...